Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Genmab (United States)

InstitutionResearch output, impact & collaborations

Genmab (United States) is a institution indexed in PICO Portal from OpenAlex.

What is known about Genmab (United States)?

PICO Portalrecord summary

Genmab (United States) is a research organisation in Princeton, US. OpenAlex records 753 works and 43,308 citations for it. 333 researchers list it as their most recent affiliation.

How many works does Genmab (United States) have?

PICO Portalindexed works

Genmab (United States) has 753 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Genmab (United States) have?

PICO Portalcitation count

Genmab (United States) has 43,308 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Genmab (United States)?

PICO Portalresearcher count

Genmab (United States) has 333 researchers in the PICO Portal index.

What is the average h-index at Genmab (United States)?

PICO Portalavg h-index

Genmab (United States) has an average h-index of 49 in OpenAlex.

What is the ROR of Genmab (United States)?

PICO Portalror

The ROR for Genmab (United States) is on the source record.

What is the OpenAlex record for Genmab (United States)?

PICO Portalopenalex

The OpenAlex for Genmab (United States) is on the source record.

What is the Wikidata of Genmab (United States)?

PICO Portalwikidata

The Wikidata for Genmab (United States) is on the source record.

Who are the most-cited researchers behind Genmab (United States)?

PICO Portaltop researchers by citations
1
Jan G. J. van de Winkel · Monoclonal and Polyclonal Antibodies Research
316 works22,332 citations
2
Neeraj N. Iyer · Hemophilia Treatment and Research
53 works679 citations

What are the most-cited papers on Genmab (United States)?

PICO Portalmost cited works
Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice
Wouter L. W. Hazenbos, J. Engelbert Gessner, Frans M.A. Hofhuis, Henri Kuipers, Dirk Meyer, Ingmar Heijnen, Reinhold Schmidt, Mátyás Sándor, P J Capel, Marc Daëron, Jan G. J. van de Winkel, J. Sjef Verbeek
Immunity. 1996448 CitationsOPEN ACCESS
Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
Michael Wang, Katharine Batt, Craig M. Kessler, Anne T. Neff, Neeraj N. Iyer, David L. Cooper, Christine L. Kempton
Patient Preference and Adherence. 201754 CitationsOPEN ACCESS
Impact of hemophilia B on quality of life in affected men, women, and caregivers—Assessment of patient‐reported outcomes in the B‐<scp>HERO</scp>‐S study
Tyler W. Buckner, Michelle Witkop, Christine Guelcher, Robert F. Sidonio, Craig M. Kessler, David B. Clark, Wendy Owens, Neil Frick, Neeraj N. Iyer, David L. Cooper
European Journal Of Haematology. 201844 CitationsOPEN ACCESS
One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy
David Portman, L.P. Shulman, Jason Yeaw, Sha Zeng, Chioma Uzoigwe, Ricardo Maamari, Neeraj N. Iyer
Menopause The Journal of The North American Menopause Society. 201536 Citations

How much of the research on Genmab (United States) is open access?

PICO Portalopen access share
92%OPEN ACCESS
Gold
42%
Green
0%
Hybrid
25%
Bronze
25%
Closed
8%

Related on PICO Portal

470M+ articles · 14-day free trial